Skip to main content

News

Roborock Holds Global No.1 Spot in Robotic Vacuums, Revenue Up 27.6%

Image
Roborock Holds Global No.1 Spot in Robotic Vacuums, Revenue Up 27.6%

Beijing – September 23, 2026 -- Roborock ranked No.1 globally in both unit shipments and sales value among robotic vacuum brands in H1 2026, according to IDC's Worldwide Quarterly Smart Vacuum Robotics Tracker for 2026Q2. The company also held the top spot in cumulative sales value among robotic vacuum brands for the period spanning Q1 2023 through Q2 2026.

Global robotic vacuum shipments reached 7.885 million units in Q2 2026

IDC data shows the market growing increasingly concentrated, with leading brands strengthening their positions as competition shifts toward technology innovation, premium products and deeper cleaning capabilities.

GROWNSY Debuts at NANN Conference, Partners on Nasal Congestion Podcast

Image
GROWNSY Debuts at NANN Conference, Partners on Nasal Congestion Podcast

West Palm Beach – September 23, 2026 -- GROWNSY, a baby care brand serving over 3 million households globally, exhibited for the first time at NANN's 42nd Annual Conference held September 15-18, 2026, in West Palm Beach, Florida, marking its entry into the neonatal clinical channel.

GROWNSY showcases NICU-to-home product line at neonatal nursing conference

The company displayed its SniffEase nasal care line alongside a Compact Bottle Sterilizer and Dryer, Electronic Infant Scale with Height Measurement, Postpartum Recovery Kit, and Perineal Massage and Pelvic Floor Wand, targeting families transitioning from NICU care to home routines.

GROWNSY CEO cites nurse engagement as strategic priority

Yvonne, CEO of GROWNSY, said meeting neonatal nurses who guide families from NICU to home reinforced the company's product development rationale.

Accels Expands AI Router to 150+ Models, Eyes Token-Based Financing

Singapore – September 22, 2026 -- Enterprise spending on AI tokens is outpacing the infrastructure built to manage it, with McKinsey reporting that enterprise LLM spending tripled over twelve months even as per-token costs fell sharply. Goldman Sachs projects token consumption will rise 24-fold by 2030, exposing a gap in how companies track and finance one of their fastest-growing cost lines.

Accels upgrades its routing platform to cover 150+ AI models

Singapore-based Accels is expanding its Accels Router product to provide access to 15 leading model providers and more than 150 AI models through a single API. The platform, which has served customers in recent years, delivers low-latency routing across large language models.

DEWALT Survey: 52% of Young Trades Talent Pushed Toward Academic Paths

Image
DEWALT Survey: 52% of Young Trades Talent Pushed Toward Academic Paths

Towson – September 22, 2026 -- A DEWALT survey of 534 WorldSkills competitors across more than 60 countries found that 76% believe technical and vocational skills are increasingly critical to the global economy, yet 51% say too few young people are entering the trades.

Survey exposes gap between perception and enrollment pathways

While 71% of respondents said the public image of skilled trades has improved, 52% reported being steered toward traditional academic paths versus just 14% encouraged into vocational careers. The disconnect starts early: 45% said young people are not exposed to skilled career opportunities soon enough, and 53% felt direct pressure to pursue university over trade training.

Exosomes Market to Hit $2.25B by 2034 on 28.8% CAGR

Image
Exosomes Market to Hit $2.25B by 2034 on 28.8% CAGR

Pune, India – – September 22, 2026 -- The global exosomes market is set to grow nearly tenfold over the next decade, expanding from USD 230.55 million in 2025 to USD 2,250 million by 2034, according to a new analysis from Maximize Market Research. The projected 28.8% compound annual growth rate between 2026 and 2034 places exosome technology among the fastest-expanding segments in biopharmaceutical R&D.

Drug delivery pipelines drive commercial momentum

Pharmaceutical and biotechnology companies are expanding exosome-related pipelines as the nanosized extracellular vesicles gain traction as targeted carriers for drugs, proteins, and RNA. Rising investment in biotechnology and advances in isolation, characterization, and engineering technologies are pushing exosomes beyond research settings into drug development and regenerative medicine applications.

WesternU Hosts Second A.P. Howells Lectureship, Launches New Honors

Image
WesternU Hosts Second A.P. Howells Lectureship, Launches New Honors

Lebanon, Ore. – September 22, 2026 -- Western University of Health Sciences Heatherington College of Osteopathic Medicine (WesternU HCOM) hosted its second annual A.P. Howells, DO, Endowed Lectureship on Aug. 29-30, 2026, training physicians in the Fascial Distortion Model (FDM) for musculoskeletal treatment.

Todd Capistrant, DO, led hands-on FDM training combining online modules with supervised clinical practice

Capistrant, a Medical Director at Foundation Health Partners since 2013 and a board-certified family medicine physician, taught participants to identify fascial distortion patterns and apply introductory osteopathic manipulative treatment techniques. He emphasized that patient activity levels remain a stronger predictor of long-term health outcomes than pharmaceutical interventions for reducing heart disease, stroke, dementia and cancer risk.

United Parks Names Miller President, Maupin Parks Operating Chief

Image
United Parks Names Miller President, Maupin Parks Operating Chief

Orlando, Fla. – September 22, 2026 -- United Parks & Resorts Inc. (NYSE: PRKS) named Kyle Miller President and elevated Scott Maupin to Chief Parks Operating Officer, effective September 22, 2026, as Chief Commercial Officer Christopher Finazzo departs the company.

Miller rises to President after three decades inside the organization

Miller moves up from Chief Parks Operations Officer to President, a role in which he will work with CEO Marc Swanson and the executive team on growth strategy and operations across the company's park portfolio. He joined Busch Entertainment Corporation in 1995 and previously served as Park President of SeaWorld Orlando, Discovery Cove and Aquatica Orlando. "Kyle has a unique understanding of our business, our culture, and our commitment to delivering experiences that matter," Swanson said.

Chainguard Becomes CVE Numbering Authority to Fight AI-Found Flaws

Image
Chainguard Becomes CVE Numbering Authority to Fight AI-Found Flaws

New York – September 22, 2026 -- Chainguard has been authorized by the CVE Program as a CVE Numbering Authority (CNA), granting it the power to assign official vulnerability identifiers for qualifying open source flaws surfaced through its Athena coalition.

Chainguard gains authority to assign CVE identifiers for unclaimed open source flaws

The CNA scope covers cases where upstream maintainers have already fixed a flaw without issuing an identifier, where no maintainer remains to assign one, or where no more specific CNA covers the affected project. Chainguard's CVE Records will defer to maintainers and project-specific CNAs wherever they exist.

OxiWear Signs Exclusive Qatar Distribution Deal with AMNM

Image
OxiWear Signs Exclusive Qatar Distribution Deal with AMNM

Doha – September 22, 2026 -- OxiWear Inc. has signed an exclusive distribution partnership with Alfardan Medical with Northwestern Medicine (AMNM) to bring its wearable physiological measurement technology into Qatar, marking the U.S. company's latest push into the Middle East.

OxiWear taps AMNM's local network to enter Qatar's healthcare technology market

Under the agreement, OxiWear and AMNM will jointly handle distribution, market development, and customer engagement for OxiWear's continuous physiological measurement products across Qatar. AMNM, a multi-specialty day-care surgery center based in Lusail and operated in affiliation with Chicago-based Northwestern Medicine, provides OxiWear with an established clinical network and regional expertise in outpatient care.

Lupus Nephritis Market to Reach $4.08B by 2034, 8.5% CAGR

Image
Lupus Nephritis Market to Reach $4.08B by 2034, 8.5% CAGR

Pune, India – September 22, 2026 -- The global lupus nephritis market was valued at $1.96 billion in 2025 and is projected to reach $4.08 billion by 2034, expanding at a compound annual growth rate of 8.5% through the forecast period, according to a new analysis by Maximize Market Research.

North America leads treatment adoption on strong pharmaceutical research capabilities

North America holds the leading position in the market, supported by advanced healthcare infrastructure and higher awareness of autoimmune diseases. The United States drives regional demand through its established pharmaceutical industry and strong clinical research activity, while Canada contributes through its developed healthcare system focused on autoimmune disease management.